Last reviewed · How we verify
Collastat
At a glance
| Generic name | Collastat |
|---|---|
| Also known as | absorbable collagen hemostasis |
| Sponsor | Yonsei University |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Collagen Fingerprinting for Stratification of PH Patients
- Regenerative Collagen Scaffold for Breast Volume Restoration After Breast Cancer Excision (NA)
- Human Repeat Insult Patch Test to Evaluate Skin Irritation and Sensitization in Healthy Volunteers (NA)
- Is Cross-linked Hyaluronic Acid a Biologic Alternative for Alveolar Ridge Preservation? (NA)
- The Effect of Collagen Scaffold Augmentation in Achilles Tendon Rupture Repair (NA)
- Targeting Collagen VII Antibodies With IV IgG in Dystrophic Epidermolysis Bullosa (PHASE1, PHASE2)
- This Study Evaluates Skin Response Following Application of a Collagen-based Material in Healthy Adult Volunteers Using a Standardized Skin Prick Test. Skin Responses Will be Assessed at Multiple Time Points Following Application, and the Study is Intended to Evaluate Dermal Safety. (NA)
- The Effectiveness of Carbonate Apatite Bone Graft for Alveolar Ridge Preservation (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Collastat CI brief — competitive landscape report
- Collastat updates RSS · CI watch RSS
- Yonsei University portfolio CI